Abstract
Long Follow-up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma (RATHL) Trial (CRUK/07/033) Confirms the Safety of Both De-Escalation and Intensification of Chemotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have